Cargando…
Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes
INTRODUCTION: Although current guidelines prefer the use of targeted testing or small-scale gene panels for identification of genetic susceptibility of hereditary endocrine tumour syndromes, next generation sequencing based strategies have been widely introduced into every day clinical practice. The...
Autores principales: | Butz, Henriett, Blair, Jo, Patócs, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016766/ https://www.ncbi.nlm.nih.gov/pubmed/33570725 http://dx.doi.org/10.1007/s12020-021-02636-x |
Ejemplares similares
-
MicroRNAs in endocrine tumors
por: Butz, Henriett, et al.
Publicado: (2019) -
Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma
por: Sarkadi, Balazs, et al.
Publicado: (2021) -
Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors
por: Krokker, Lilla, et al.
Publicado: (2021) -
Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice
por: Butz, Henriett, et al.
Publicado: (2020) -
Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
por: Sarkadi, Balazs, et al.
Publicado: (2022)